Methods Multicenter study in 9 European centers on patients with biopsy proven neoplastic
BE. Therapeutic concept: Combination of endoresection (EMR/ESD) plus maximum of 5 H …

Background and study aim: Argon plasma coagulation (APC) has been used to ablate
dysplastic and nondysplastic Barrett's esophagus. We determined the longer-term efficacy of …

BACKGROUND: Endoscopic ablation of Barrett's esophagus has been described in which
various thermocoagulation modalities are used in combination with a high dose of a proton …

BACKGROUND Complete reversal of Barrett's epithelium (BE) achieved by treatment with
argon plasma coagulation (APC) is variable. The aim of this prospective study was to …

AIM: This prospective study evaluated the effectiveness of 90 W argon plasma coagulation
(APC) for the ablation of Barrett's esophagus (BE) that is considered to be the main risk …

This prospective trial evaluated endoscopic thermoablation with argon plasma coagulation
(APC) in the treatment of 50 Barrett's esophagus (BE) patients with low grade or no …

METHODS: Consecutive patients with neoplastic BE undergoing ablation after curative
endoscopic resection (89.6%) or primarily were included into this prospective trial in 9 …

To the Editor: The incidence of esophageal adenocarcinoma has increased sixfold over the
past 30 year in the USA [1]. Whereas esophageal adenocarcinomas arise from Barrett's …

As the incidence of esophageal adenocarcinoma increases in the United States, detection,
diagnosis, and treatment for Barrett's esophagus (BE) is even more critical. 1 BE-related …

OP In Europe, nondysplastic Barrett esophagus is usually treated with proton pump
inhibitors and surveillance; ablative therapy of nondysplastic Barrett esophagus is not …